184
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Is placebo useful in the treatment of major depression in clinical practice?

, , &
Pages 915-920 | Published online: 25 Jun 2013

References

  • RiefWNestoriucYWeissSWelzelEBarskyAJHofmannSGMeta-analysis of the placebo response in antidepressant trialsJ Affect Disord20091181819246102
  • KhanAKoltsRLRapaportMHKrishnanKRBrodheadAEBrownsWAMagnitude of placebo response and drug-placebo differences across psychiatric disordersPsychol Med20053574374915918351
  • KirschIDeaconBJHuedo-MedinaTBScoboriaAMooreTJJohnsonBTInitial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug AdministrationPLoS Med20085260268
  • FournierJCDe RubeisRJHollonSDAntidepressant drug effects and depression severity, a patient-level meta-analysisJAMA2010303475320051569
  • HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
  • LeuchtCHuhnMLeuchtSAmitriptyline versus placebo for major depressive disorderCochrane Database Syst Rev201212CD00913823235671
  • MathewSJCharneyDSPublication bias and the efficacy of antidepressantsAm J Psychiatry200916614014519188290
  • UndurragaJBaldessariniRJRandomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic reviewNeuropsychopharmacology20123785186422169941
  • ArrollBElleyCRFishmanTAntidepressants versus placebo for depression in primary careCochrane Database Syst Rev20093CD00795419588448
  • KesslerRCBerglundPDemlerOThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA20032893095310512813115
  • ZimmermanMPosternakMAChelminskiISymptom severity and exclusion from antidepressant efficacy trialsJ Clin Psychopharmacol20022261061412454561
  • WalshBTSeidmanSNSyskoRGouldMPlacebo response in studies of major depression: variable, substantial and growingJAMA20022871840184711939870
  • ParkerGIs depression overdiagnosed? YesBMJ200733532917703041
  • PincusHADavisWWMcQueenLE‘Subthreshold’ mental disorders. A review and synthesis of studies on minor depression and other ‘brand names’Br J Psychiatry199917428829610533546
  • BarthJSchumacherMHerman-LingenCDepression as a risk factor for mortality in patients with coronary heart disease: a meta-analysisPsychosom Med20046680281315564343
  • MastrogiannisDGiamouzisGDardiotisEDepression in patients with cardiovascular diseaseCardiol Res Pract2012201279476222830072
  • HaJHWongCKPharmacologic treatment of depression in patients with myocardial infarctionJ Geriatr Cardiol2011812112622783296
  • BaumeisterHHutterNBengelJPsychological and pharmacological interventions for depression in patients with coronary artery diseaseCochrane Database Syst Rev20119CD00801221901717
  • WeihsKWertJMA primary care focus on the treatment of patients with major depressive disorderAm J Med Sci201134232433021642822
  • PrinceMPatelVSaxenaSNo health without mental healthLancet200737085987717804063
  • BarbuiCCiprianiAPatelVAyuso-MateosJLvan OmmerenMEfficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysisBr J Psychiatry2011198111621200071
  • RutherfordBRMoriSSneedJRPimontelMARooseSPContribution of spontaneous improvement to placebo response in depression: a meta-analytic reviewJ Psychiatr Res20124669770222410207
  • BerthelotJMLe GoffBMaugarsYThe Hawthorne effect: stronger than the placebo effect?Joint Bone Spine20117833533621742532
  • HaourFMechanism of the placebo effect and of conditioningNeuroimmunomodulation20051219520015990450
  • WolfSThe pharmacology of placebosPharmacol Rev19591168970413845665
  • GoldsteinAPParticipant expectancies in psychotherapyPsychiatry196225727913899878
  • PolloAAmanzioMArslanianACasadioCMaggiGBenedettiFResponse expectancies in placebo analgesia and their clinical relevancePain200193778411406341
  • SunshineALaskaEMeisnerMMorganSAnalgesic studies of indomethacin as analyzed by computer techniquesClin Pharmacol Ther19646669970714226185
  • AderRThe role of conditioning in pharmacotherapyHarringtonAThe Placebo Effect: An Interdisciplinary ExplorationCambridge, MAHarvard University Press1997
  • Di BlasiZHarknessEErnstEGeorgiouAKleijnenJInfluence of context effect on health outcomes. A systemic reviewLancet200135775776211253970
  • ThomasKBThe placebo in general practiceLancet1994344106610677934451
  • BrodyHThe lie that heals: the ethics of giving placeboAnn Intern Med1982971121187046551
  • SinyorMLevittAJCheungAHDoes inclusion of a placebo arm influence response to active antidepressant treatment in RCT? Results from pooled and meta-analysesJ Clin Psychiatry20107127027920122371
  • SneedJRRutherfordBRRindskopfDLaneDTSackeimHARooseSPDesign makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depressionAm J Geriatr Psychiatry200816657317998306
  • CollocaLMillerFGRole of expectations in healthCurr Opin Psychiatry20112414915521248640
  • FrankJDPsychotherapy: the restoration of moraleAm J Psychiatry19741312712744812687
  • MarchesiCMagginiCSocio-demographic and clinical features associated with demoralization in medically ill in-patientsSoc Psychiatry Psychiatr Epidemiol20074282482917622475
  • KleinDFEndogenomorphic depression. A conceptual and terminological revisionArch Gen Psychiatry1974314474544420562
  • de la Fuente-FernándezRThe placebo-reward hypothesis: dopamine and the placebo effectParkinsonism Relat Disord200915 Suppl 3S72S7420083013
  • LidstoneSCSchulzerMDinelleKEffects of expectation on placebo-induced dopamine release in Parkinson diseaseArch Gen Psychiatry20106785786520679593
  • BloodAJIosifescuDVMakrisNMicrostructural abnormalities in subcortical reward circuitry of subjects with major depressive disorderPLoS One20105e1394521124764
  • Der-AvakianAMarkouAThe neurobiology of anhedonia and other reward-related deficitsTrends Neurosci201235687722177980
  • ScottDJStohlerCSEgnatukCMWangHKoeppeRAZubietaJKPlacebo and nocebo effects are defined by opposite opioid and dopaminergic responsesArch Gen Psychiatry20086522023118250260
  • SeemüllerFMöllerHJObermeierMDo efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trialsJ Clin Psychiatry2010711425143320816028
  • PosternakMAZimmermanMTherapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysisBr J Psychiatry200719028729217401033
  • IovienoNTedeschiniELevkovitzYAmeralVEPapakostasGIDoes the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trialsInt J Neuropsychopharmacol20111821557881
  • WisniewskiSRRushAJNierenbergAACan phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D reportAm J Psychiatry200916659960719339358
  • NaudetFMariaASFalissardBAntidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studiesPLoS One20116e2081121687681
  • HegerlUMerglRThe clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differencesJ Psychopharmacol20102444544819825901
  • KirschIPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences. PrefacePhilos Trans R Soc Lond B Biol Sci20113661781178221576134
  • KaptchukTJFriedlanderEKelleyJMPlacebos without deception: a randomized controlled trial in irritable bowel syndromePLoS One20105e1559121203519
  • YathamLNKennedySHSchafferACanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disord20091122525519419382
  • American Psychiatric AssociationPractice Guideline for the Treatment of Patients With Major Depressive Disorder3rd edArlington, VAAmerican Psychiatric Association2010 Available from: http://www.guidelines.gov/content.aspx?id=24158Accessed June 8, 2013
  • National Institute for Clinical ExcellenceThe treatment and management of depression in adults (CG90) Issued Oct 2009. Available from: http://www.nice.org.uk/CG90Accessed June 8, 2013
  • AndersonIMFerrierINBaldwinRCEvidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelinesJ Psychopharmacol20082234339618413657
  • HansenBHHanashJARasmussenAEffects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD)J Psychosom Res201272111622200516
  • TaylorCBYoungbloodMECatellierDENRICHD InvestigatorsEffects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarctionArch Gen Psychiatry20056279279815997021
  • LespéranceFFrasure-SmithNKoszyckiDEffects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trialJAMA200729736737917244833